Ioana Buculei Porosnicu, L. Trofor, C. Vicol, I. Grosu, Alexandra Tifrea, C. Vardavas, P. Behrakis, A. Trofor
{"title":"“Lung age” – a motivational smoking cessation tool in smokers with chronic obstructive pulmonary disease","authors":"Ioana Buculei Porosnicu, L. Trofor, C. Vicol, I. Grosu, Alexandra Tifrea, C. Vardavas, P. Behrakis, A. Trofor","doi":"10.1183/13993003.CONGRESS-2018.PA1234","DOIUrl":null,"url":null,"abstract":"Introduction: Tobacco use is the major risk factor in chronic obstructive pulmonary disease and has an important contribution to premature lung ageing(1). Aim: To assess the impact of “lung age” measurement on cessation rates in COPD smokers, in a personalized smoking cessation (SC) intervention versus standard of care. Methods: Current smokers with COPD were enrolled in a SC program in Group 1 (50 patients) receiving standard of care intervention(baseline evaluation, counseling, biochemical validation, follow-up)and Group 2 (50 patients) who attended a pilot SC intervention (personalized evaluation and counseling with “lung age” measures, biochemical validation, follow-up) based on the EU TOB G project guideline for high risk populations. No pharmacological SC therapy was provided. Results: Self-reported smoking abstinence was significantly increased at the 1, 2, and 6-month follow-up in Group 2 (30.6%, 44.0% and 64.0% abstinent) versus 16%, 24% and 40%, respectively in Group 1. Carbon monoxide validation was achieved in 20% of Group 1 and in 51.6% of Group 2. The bio-chemically verified abstinent rate at 6 months follow-up was significantly higher in Group 2 (33.3%, p Conclusions: The “lung age” tool adds value in a personalized non-pharmacological smoking cessation intervention for COPD patients, by urging intention to quit. (1) Trofor A.,Petris O.,Trofor L.,Man M.A.,Filipeanu D.,Miron R. Biochemistry in assessing tobacco exposure-smokers versus non-smokers-correlations with clinical practice. Revista de Chimie.2017.68(5):1002-1006.","PeriodicalId":212819,"journal":{"name":"Tobacco, smoking control and health education","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tobacco, smoking control and health education","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA1234","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Introduction: Tobacco use is the major risk factor in chronic obstructive pulmonary disease and has an important contribution to premature lung ageing(1). Aim: To assess the impact of “lung age” measurement on cessation rates in COPD smokers, in a personalized smoking cessation (SC) intervention versus standard of care. Methods: Current smokers with COPD were enrolled in a SC program in Group 1 (50 patients) receiving standard of care intervention(baseline evaluation, counseling, biochemical validation, follow-up)and Group 2 (50 patients) who attended a pilot SC intervention (personalized evaluation and counseling with “lung age” measures, biochemical validation, follow-up) based on the EU TOB G project guideline for high risk populations. No pharmacological SC therapy was provided. Results: Self-reported smoking abstinence was significantly increased at the 1, 2, and 6-month follow-up in Group 2 (30.6%, 44.0% and 64.0% abstinent) versus 16%, 24% and 40%, respectively in Group 1. Carbon monoxide validation was achieved in 20% of Group 1 and in 51.6% of Group 2. The bio-chemically verified abstinent rate at 6 months follow-up was significantly higher in Group 2 (33.3%, p Conclusions: The “lung age” tool adds value in a personalized non-pharmacological smoking cessation intervention for COPD patients, by urging intention to quit. (1) Trofor A.,Petris O.,Trofor L.,Man M.A.,Filipeanu D.,Miron R. Biochemistry in assessing tobacco exposure-smokers versus non-smokers-correlations with clinical practice. Revista de Chimie.2017.68(5):1002-1006.